Edoxaban Impurity 75 | CAS 365998-34-1 - Request Quote
Edoxaban Impurity 75
| SZ CAT No: | SZ-E041089 |
| CAS No | 365998-34-1 |
| Mol.F. | C20H28N2O6 |
| Mol.Wt. | 392.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Edoxaban Impurity 75 is chemically (1S,3R,4S)-4-(((benzyloxy)carbonyl)amino)-3-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylic acid. Edoxaban Impurity 75 is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 75 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 365998-34-1
Purchase 365998-34-1
Order 365998-34-1
Enquire 365998-34-1
price of 365998-34-1
365998-34-1 Supplier
365998-34-1 Manufacturer
365998-34-1 Exporter
buy high quality Edoxaban Impurity 75
Purchase Edoxaban Impurity 75
Edoxaban Impurity 75 suppliers
Edoxaban Impurity 75 manufacturers
Edoxaban Impurity 75 price
Order Edoxaban Impurity 75
Enquire Edoxaban Impurity 75
Edoxaban Impurity 75 cost
Edoxaban Impurity 75 Supplier
Edoxaban Impurity 75 Distributor
Edoxaban Impurity 75 for Method Validation
Edoxaban Reference Standard
Edoxaban Impurity 75 for ANDA Filing
Edoxaban Impurity 75 for Forced Degradation Studies
Edoxaban Impurity 75 Identification Standards
Edoxaban Impurity 75 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.